Results 21 to 30 of about 401,321 (268)
Host-Directed Therapies for Cutaneous Leishmaniasis
Frontiers in Immunology, 2021 Cutaneous leishmaniasis exhibits a wide spectrum of clinical presentations from self-resolving infections to severe chronic disease. Anti-parasitic drugs are often ineffective in the most severe forms of the disease, and in some cases the magnitude of ...
F. Novais, C. Amorim, P. Scott
semanticscholar +1 more source
Clinical Case Reports, 2021 Clinicians should always consider rare, atypical, and opportunistic infections in patients undergoing long‐term systemic corticosteroid therapy. Diagnosis needs further evaluations and special consideration.
Maryam Mahdavi +4 more
doaj +1 more source
Coinfection of Leishmania (Viannia) braziliensis and Streptococcus pneumoniae in multiple cutaneous lesions [PDF]
, 2016 Key learning points Cutaneous leishmaniasis is the most common clinical disease caused by all the Leishmania species that are pathogenic to humans. Other bacterial coinfections of Leishmania lesions have been described, but this is the first report of ...
Chiapello, Laura Silvina +6 more
core +11 more sources
A Case Report of a Successful Allergen Immunotherapy with Candida Albicans in Patient with Sever Atopic Dermatitis Sensitive to Candida Albicans [PDF]
Patient Safety and Quality Improvement Journal, 2019 Introduction: Atopic dermatitis (AD) is an inflammatory, chronic, relapsing, itchy skin disease with an immunologic basis. This disease is associated with itchy skin lesions (pruritus), dry skin (xerosis) and plaques of eczema. The role of aeroallergens,
Farahzad Jabbari Azad +3 more
doaj +1 more source
The Moldovan Medical Journal, 2018 Background: Leishmaniasis is a disease caused by parasites of the Leishmania type. Cutaneous leishmaniasis (CL) is a neglected worldwide, zoonotic, vector-borne, tropical disease. The clinical spectrum of leishmaniasis ranges from a self-resolving cutaneous ulcer to a mutilating mucocutaneous disease and even to a lethal systemic illness.
Placinta, Gheorghe +8 more
openaire +4 more sources
Recurrent cutaneous leishmaniasis [PDF]
Anais Brasileiros de Dermatologia, 2013 We present a case of an 18-year-old male patient who, after two years of inappropriate treatment for cutaneous leishmaniasis, began to show nodules arising at the edges of the former healing scar. He was immune competent and denied any trauma. The diagnosis of recurrent cutaneous leishmaniasis was made following positive culture of aspirate samples ...
Gomes, Ciro Martins +4 more
openaire +4 more sources
The evaluation of herbal medicine efficacy on cutaneous Leishmaniasis [PDF]
Reviews in Clinical Medicine, 2014 Leishmaniasis including Cutaneous, mocucutaneous and Visceral forms of clinical syndromes is one of the important health care problem in the world specially in developing countries.
Zohre Seidi
doaj +3 more sources
Systemic Treatments of Leishmaniasis: A Narrative Review [PDF]
Reviews in Clinical Medicine, 2019 Cutaneous leishmaniasis is a prevalent parasitic infection in humans. According to the reports published in several localities across the world, leishmaniasis is an endemic disease in certain regions in Iran.
Ahmad Reza Taheri +2 more
doaj +1 more source
Frontiers in Public Health, 2020 Leishmania tropica and Leishmania major are both the main cause of anthroponotic (ACL) and zoonotic cutaneous leishmaniasis (ZCL), respectively, in the Old World.
M. A. Ghatee, W. Taylor, M. Karamian
semanticscholar +1 more source
Native rodent species are unlikely sources of infection for Leishmania (Viannia) braziliensis along the Transoceanic Highway in Madre de Dios, Peru. [PDF]
, 2014 An estimated 2.3 million disability-adjusted life years are lost globally from leishmaniasis. In Peru's Amazon region, the department of Madre de Dios (MDD) rises above the rest of the country in terms of the annual incidence rates of human leishmaniasis.
Conrad, Patricia A +7 more
core +9 more sources